SPDR S&P Pharmaceuticals ETF Rating $48.34 -0.29 (-0.60%) Closing price 10/7/2025 04:10 PM EasternExtended Trading$48.17 -0.17 (-0.35%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.61Holdings in XPH have an aggregate rating of Moderate Buy based on 291 analyst ratings issued in the past year covering 25 companies (64.2% of the portfolio).XPH Aggregate Price Target$48.34High Prediction$48.34Average Prediction$48.34Low Prediction$48.34Holdings in XPH have an aggregate price target of $48.34 and a range of $48.34 to $48.34 covering 25 companies (64.2% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.22%CRNXCrinetics Pharmaceuticals$42.50+2.0%3.8879 of 5 stars2.71$74.45 75.2%14High Trading Volume3.04%CORTCorcept Therapeutics$90.32+0.5%4.9149 of 5 stars2.57$135.25 49.7%72.77%ELANElanco Animal Health$20.49-0.8%2.7063 of 5 stars2.91$19.14 -6.6%11News CoverageAnalyst Upgrade2.77%TARSTarsus Pharmaceuticals$68.42+1.0%0.7709 of 5 stars2.50$66.67 -2.6%82.70%LGNDLigand Pharmaceuticals$183.16+0.3%3.9994 of 5 stars2.71$176.50 -3.6%72.68%JNJJohnson & Johnson$188.95+0.4%4.6988 of 5 stars2.68$189.88 0.5%22Trending NewsUpcoming EarningsAnalyst ForecastGap Down2.67%SUPNSupernus Pharmaceuticals$48.07-0.5%3.3757 of 5 stars2.80$51.50 7.1%52.65%HROWHarrow$41.90-0.6%2.9398 of 5 stars2.67$68.50 63.5%92.64%JAZZJazz Pharmaceuticals$137.32-0.2%4.618 of 5 stars2.76$178.93 30.3%172.61%OGNOrganon & Co.$10.60-2.2%4.7704 of 5 stars2.50$17.33 63.6%6Positive News2.55%PRGOPerrigo$21.72-1.5%4.9292 of 5 stars2.20$34.00 56.6%5Positive News2.53%RPRXRoyalty Pharma$36.10-0.1%4.7941 of 5 stars3.00$46.00 27.4%52.52%PFEPfizer$26.27-0.6%4.9206 of 5 stars2.37$28.41 8.2%19Trending News2.50%LLYEli Lilly and Company$844.30-0.1%4.9943 of 5 stars2.64$943.00 11.7%25Trending NewsAnalyst Forecast2.49%OCULOcular Therapeutix$11.52+5.0%3.983 of 5 stars2.75$22.63 96.4%12Analyst ForecastInsider Trade2.48%ZTSZoetis$142.91-1.7%4.867 of 5 stars2.50$200.88 40.6%10Positive News2.47%PBHPrestige Consumer Healthcare$62.85-0.5%4.4706 of 5 stars2.43$94.80 50.8%72.46%AXSMAxsome Therapeutics$118.64-1.1%4.7826 of 5 stars3.00$177.93 50.0%17Analyst Revision2.45%ANIPANI Pharmaceuticals$91.68-0.4%3.6915 of 5 stars3.00$97.29 6.1%102.44%VTRSViatris$10.14+0.1%1.7703 of 5 stars1.67$10.40 2.6%62.43%BMYBristol Myers Squibb$44.63-1.1%4.9828 of 5 stars2.33$57.14 28.0%21Positive News2.42%MRKMerck & Co., Inc.$87.63-1.3%4.9957 of 5 stars2.29$104.31 19.0%21Positive News2.36%INVAInnoviva$17.20-1.3%4.7749 of 5 stars2.50$37.60 118.6%6News Coverage2.17%LQDALiquidia Technologies$24.02+5.1%3.4437 of 5 stars2.70$32.38 34.8%10News CoverageAnalyst Forecast2.16%HRMYHarmony Biosciences$27.05+1.7%4.611 of 5 stars2.91$45.50 68.2%11 This page (NYSEARCA:XPH) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
